<![CDATA[FDA Grants Fast Track Designation to FG001 for High-Grade Glioma Surgery]]>
The FDA has granted fast track designation to FG001, a fluorescent imaging agent targeting the urokinase-type plasminogen activator receptor (uPAR), for use as an intraoperative imaging agent guide during the surgical resection of high-grade glioma (HGG), …